Zymeworks
Latest round
- Series A
Last raised
- Jan 2016
Total raised
- $80M
Investors
- 14
About Zymeworks
Founded in 2003 and headquartered in Vancouver, Canada, Zymeworks Inc. is a biotechnology firm dedicated to developing innovative therapeutics for serious health conditions, focusing primarily on oncology, inflammation, and autoimmune diseases through advanced antibody technology. Zymeworks Inc. specializes in biopharmaceutical development, particularly in the creation of multifunctional therapeutics. The company has not reported any significant pivots in business strategy. Kenneth Galbraith serves as the current CEO of Zymeworks Inc.. The company develops novel, multifunctional therapeutics specifically designed to address healthcare needs in oncology, inflammation, and autoimmune diseases. Its flagship product, zanidatamab, is a HER2-targeted bispecific antibody utilizing the proprietary Azymetric™ technology, aimed at treating adults with unresectable or metastatic HER2-positive biliary tract cancer.S. FDA and conditional approval from China's NMPA. Zymeworks Inc.53 mn. The company generates revenue primarily through strategic partnerships and exclusive licensing agreements with other biopharmaceutical firms, where partners commercialize Zymeworks' products in specific territories. The company is also targeting expansion into new geographic markets to enhance its global presence. In March 2026, Royalty Pharma agreed to issue a USD 250 million non-recourse royalty-backed notes to Zymeworks Inc. with repayments due from 30% of worldwide tiered royalties on its product, Ziihera.
Who invested in Zymeworks
14 investors across 3 rounds
See all investors in Zymeworks
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zymeworks
Who invested in Zymeworks?
Zymeworks has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zymeworks raised?
Zymeworks has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Zymeworks last raise money?
Zymeworks's most recent round on record is a Series A, in Jan 2016.
What does Zymeworks do?
Founded in 2003 and headquartered in Vancouver, Canada, Zymeworks Inc.
Where is Zymeworks headquartered?
Zymeworks is headquartered in Vancouver, Canada.
Which VCs invest in companies like Zymeworks?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Zymeworks's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Zymeworks? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.